Skip to main content
. 2016 Mar 16;263:927–936. doi: 10.1007/s00415-016-8051-1

Fig. 1.

Fig. 1

CFD score progression over time. Data based on total observation period across all patients. Zero time point on x-axis represents start of miglustat treatment; thick coloured lines represent average prediction based on linear mixed-effects analysis, and thinner grey lines represent individual patient data